6-fluoro-3-tyrosine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
Studies (6-fluoro-3-tyrosine) | Trials (6-fluoro-3-tyrosine) | Recent Studies (post-2010) (6-fluoro-3-tyrosine) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
---|---|---|---|---|---|
19 | 0 | 2 | 3,859 | 8 | 1,052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bankiewicz, KS; Eberling, JL; Jagust, WJ; Jordan, S; VanBrocklin, HF | 1 |
Bankiewicz, KS; Bringas, J; Eberling, JL; Jagust, WJ; Pivirotto, P; Taylor, S; VanBrocklin, HF | 1 |
Bankiewicz, KS; Bringas, J; Budinger, TF; Cunningham, J; Eberling, JL; Harvey-White, J; Jagust, W; Kohutnicka, M; Pivirotto, P | 1 |
Bankiewicz, KS; Eberling, JL; Emborg, ME; Nagy, D; Oiwa, Y; Pivirotto, P | 1 |
4 other study(ies) available for 6-fluoro-3-tyrosine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
PET studies of functional compensation in a primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Progression; Dopamine Agents; Fluorine Radioisotopes; Macaca mulatta; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Neurotoxins; Pargyline; Parkinson Disease, Secondary; Tomography, Emission-Computed; Tyrosine | 1997 |
A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Macaca mulatta; Parkinson Disease, Secondary; Tomography, Emission-Computed; Tyrosine | 1998 |
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Catheterization; Caudate Nucleus; Cell Line; Dependovirus; Dopamine; Drug Administration Routes; Drug Combinations; Fluorine Radioisotopes; Genetic Therapy; Genetic Vectors; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Neurons; Parkinson Disease, Secondary; Prodrugs; Putamen; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase | 2000 |
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Carotid Arteries; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Histocytochemistry; Humans; Injections, Intra-Arterial; Macaca mulatta; Male; Neurochemistry; Parkinson Disease, Secondary; Parkinsonian Disorders; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase | 2003 |